 1. A banking organization must account for dependence between exposure and counterparty's credit quality in regulatory CVA calculations. 
2. For margined counterparties, only qualifying financial collateral can be recognized as a risk mitigant. 
3. Simulated paths of discounted future exposure must capture the effects of margining collateral and relevant contractual features. 
4. A banking organization must obtain simulated paths using the same CVA exposure models used for financial reporting, adjusted to meet the requirements of this section. 
5. CVA delta and vega sensitivities must be calculated in accordance with specified definitions and methodologies.